Cho H, Park K, Oh E, Lee M, Choi B, Im E
Innate Immun. 2024; :17534259241306237.
PMID: 39711480
PMC: 11664557.
DOI: 10.1177/17534259241306237.
Izuora K, Alver A, Basu A, Batra K, Williams S, Ebersole J
Healthcare (Basel). 2024; 12(18).
PMID: 39337145
PMC: 11431254.
DOI: 10.3390/healthcare12181804.
Yin Q, Guo N, Fu P, Zhong H
Open Med (Wars). 2024; 19(1):20241035.
PMID: 39308920
PMC: 11416072.
DOI: 10.1515/med-2024-1035.
Helfer-Hungerbuehler A, Spiri A, Meili T, Riond B, Krentz D, Zwicklbauer K
Viruses. 2024; 16(5).
PMID: 38793672
PMC: 11125897.
DOI: 10.3390/v16050791.
Legger G, Dermer C, Brunger A, van Daele P, Nienhuis H
Pediatr Rheumatol Online J. 2022; 20(1):106.
PMID: 36434581
PMC: 9700917.
DOI: 10.1186/s12969-022-00757-9.
The Association of Prenatal C-Reactive Protein and Interleukin-8 Levels with Maternal Characteristics and Preterm Birth.
Chen Y, Mirzakhani H, Knihtila H, Fichorova R, Luu N, Laranjo N
Am J Perinatol. 2022; 41(S 01):e843-e852.
PMID: 36241210
PMC: 10244485.
DOI: 10.1055/a-1961-2425.
Relationship between biomarkers and findings on low-dose computed tomography in hospitalised patients with acute exacerbation of COPD.
Prins H, Duijkers R, Kramer G, Boerhout E, Rietema F, de Jong P
ERJ Open Res. 2022; 8(2).
PMID: 35747233
PMC: 9209851.
DOI: 10.1183/23120541.00054-2022.
Role of Clinical Characteristics and Biomarkers at Admission to Predict One-Year Mortality in Elderly Patients with Pneumonia.
Malezieux-Picard A, Azurmendi L, Pagano S, Vuilleumier N, Sanchez J, Zekry D
J Clin Med. 2022; 11(1).
PMID: 35011845
PMC: 8745347.
DOI: 10.3390/jcm11010105.
Preoperative Inflammatory Markers as a Predictor of Three-Year Overall Survival in Older Cancer Patients Undergoing Oncologic Surgery.
Brattinga B, Rutgers A, de Haan J, Absalom A, van der Wal-Huisman H, de Bock G
Cancers (Basel). 2021; 13(8).
PMID: 33920422
PMC: 8069748.
DOI: 10.3390/cancers13081824.
Serum amyloid A concentrations, COVID-19 severity and mortality: An updated systematic review and meta-analysis.
Zinellu A, Paliogiannis P, Carru C, Mangoni A
Int J Infect Dis. 2021; 105:668-674.
PMID: 33737133
PMC: 7959678.
DOI: 10.1016/j.ijid.2021.03.025.
Serum Amyloid A in Inflammatory Rheumatic Diseases: A Compendious Review of a Renowned Biomarker.
Soric Hosman I, Kos I, Lamot L
Front Immunol. 2021; 11:631299.
PMID: 33679725
PMC: 7933664.
DOI: 10.3389/fimmu.2020.631299.
Accuracy of C-reactive protein, procalcitonin, serum amyloid A and neopterin for low-dose CT-scan confirmed pneumonia in elderly patients: A prospective cohort study.
Prendki V, Malezieux-Picard A, Azurmendi L, Sanchez J, Vuilleumier N, Carballo S
PLoS One. 2020; 15(9):e0239606.
PMID: 32997689
PMC: 7526885.
DOI: 10.1371/journal.pone.0239606.
A Clinical Prediction Score Including Trial of Antibiotics and C-Reactive Protein to Improve the Diagnosis of Tuberculosis in Ambulatory People With HIV.
Boyles T, Nduna M, Pitsi T, Scott L, Fox M, Maartens G
Open Forum Infect Dis. 2020; 7(2):ofz543.
PMID: 32042850
PMC: 7000838.
DOI: 10.1093/ofid/ofz543.
Serum amyloid A levels in patients with liver diseases.
Yuan Z, Zhang X, Wu Y, Zeng Z, She W, Chen S
World J Gastroenterol. 2019; 25(43):6440-6450.
PMID: 31798280
PMC: 6881510.
DOI: 10.3748/wjg.v25.i43.6440.
Usefulness of the heparin-binding protein level to diagnose sepsis and septic shock according to Sepsis-3 compared with procalcitonin and C reactive protein: a prospective cohort study in China.
Zhou Y, Liu Z, Huang J, Li G, Li F, Cheng Y
BMJ Open. 2019; 9(4):e026527.
PMID: 31015272
PMC: 6502053.
DOI: 10.1136/bmjopen-2018-026527.
The risk of febrile neutropenia in breast cancer patients following adjuvant chemotherapy is predicted by the time course of interleukin-6 and C-reactive protein by modelling.
Netterberg I, Karlsson M, Nielsen E, Quartino A, Lindman H, Friberg L
Br J Clin Pharmacol. 2017; 84(3):490-500.
PMID: 29178353
PMC: 5809342.
DOI: 10.1111/bcp.13477.
Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker.
Hwang Y, Balasubramani G, Metes I, Levesque M, Bridges Jr S, Moreland L
Arthritis Res Ther. 2016; 18(1):108.
PMID: 27188329
PMC: 4869396.
DOI: 10.1186/s13075-016-1009-y.
Serum Amyloid A as a Biomarker for Radiation Exposure.
Sproull M, Kramp T, Tandle A, Shankavaram U, Camphausen K
Radiat Res. 2015; 184(1):14-23.
PMID: 26114330
PMC: 4710171.
DOI: 10.1667/RR13927.1.
Characterization of the contributions of Hp-MMP 9 to the serum acute phase protein response of lipopolysaccharide challenged calves.
Hinds C, Niehaus A, Premanandan C, Rajala-Schultz P, Rings D, Lakritz J
BMC Vet Res. 2014; 10:261.
PMID: 25358728
PMC: 4220046.
DOI: 10.1186/s12917-014-0261-0.
Mechanism-based approach using a biomarker response to evaluate tocilizumab subcutaneous injection in patients with rheumatoid arthritis with an inadequate response to synthetic DMARDs (MATSURI study).
Ohta S, Tsuru T, Terao K, Mogi S, Suzaki M, Shono E
J Clin Pharmacol. 2013; 54(1):109-19.
PMID: 24115082
PMC: 3908364.
DOI: 10.1002/jcph.185.